Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more

JAMA Editor’s Summary

Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more

Editors' Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the , issue.

October 25, 2022

Listen on your favorite player Take me to this show’s page

Newer →

Health Care Access and Reproductive Rights: Research, Viewpoints, Editorials, and more.

← Older

Spinal Cord Stimulation for Chronic Back Pain, Prescription Drug Spending in Medicare, USPSTF Recommendation on Screening for Depression and Suicide Risk in Children and Adolescents, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more

Editors’ Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 25, 2022, issue.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00